Rapid Novor Inc. Launches REmAb™ Antibody Protein Sequencing Services on Science Exchange

January 24, 2018 | Posted by Team in Drug Discovery, New Innovations, Press Release, Research |

PALO ALTO, CA, January 25, 2018 – Science Exchange, the world’s leading and most secure enterprise platform for outsourced research and development (R&D) services, announced a partnership with Rapid Novor Inc to offer its REmAb™ Antibody Protein Sequencing Services to scientists around the world using Science Exchange’s R&D platform.

Rapid Novor, Inc. is a Kitchener-Waterloo (Canada)-based CRO dedicated to the development of antibody protein sequencing technologies. The company’s mission is to advance life science research to better human health with next-generation protein sequencing. With the opening of its own state-of-the-art mass spectrometry lab in 2017, the team has successfully sequenced hundreds of monoclonal antibodies directly from the proteins and helped pharmaceutical companies in their antibody drug discovery.

“Our focus is on the development of antibody protein sequencing technologies, and we are the only team that has both a mass spectrometry lab and proprietary sequencing software platform,” said Mingjie Xie, Co-founder and CEO of Rapid Novor, Inc. “We are uniquely positioned to offer superior protein sequencing services to researchers worldwide. The partnership with Science Exchange will allow us to provide easy-to-access services to enterprise biopharma companies and offer them cutting-edge technologies in a seamless manner.”

“We are thrilled to partner with Rapid Novor Inc to make its REmAb™ Antibody Protein Sequencing Services available to scientists worldwide,” said Elizabeth Iorns, Ph.D., co-founder and CEO of Science Exchange. “By partnering with the leading CROs in different research and technology sectors, we are bringing in the best and brightest service providers to our secure and readily available platform so that the scientists can focus on developing breakthrough discoveries. Having Rapid Novor Inc as part of our supplier portfolios is an example of our commitment to making it easy for researchers to access the world’s leading scientific service providers and most innovative scientific technologies.”

About Rapid Novor, Inc.

Rapid Novor, Inc. is the world’s leader in antibody protein sequencing technology. Specializing in the field of mass spectrometry-based proteomics, the team has developed the technology to directly sequence the antibody proteins without needs to access the cell line. As a University of Waterloo spin-off, the company is building its technology portfolios based on the twenty years of scientific research and inventions from Dr. Bin Ma, co-founder and chief scientist. The company’s REmAb™ antibody protein sequencing service has allowed the accurate sequencing of any given antibody proteins routinely. The company’s WILD™ service is the first commercially available service that can accurately distinguish the isomeric isoleucine and leucine using mass spectrometry. For more information, visit www.rapidnovor.com. Follow the company on Twitter @rapidnovor.

Nanome Partners with Science Exchange to Offer Virtual Reality Drug Design Tools and Blockchain Solutions to Scientists

January 18, 2018 | Posted by Team in Drug Discovery, New Innovations, Press Release |

Nanome Partners with Science Exchange

PALO ALTO, CA, January 18, 2018 Science Exchange, the world’s leading and most secure enterprise platform for outsourced research and development (R&D) services, announced a partnership with Nanome Inc. to offer scientists on-demand access to Nanome’s blockchain and virtual reality technology.

Nanome is a San Diego-based company whose mission is to democratize science through blockchain technology and virtual reality tools to aid in the progression of molecular precision and advancements in nanotechnology.

“We can revolutionize the way science is done through our virtual reality drug design tool, NanoPro, and the Matryx blockchain platform,” said Steve McCloskey, CEO and Founder of Nanome. “Historically, scientists have had problems with collaboration and efficiency in their research, so we are excited to partner with Science Exchange to accelerate scientific development across the world.”

“We are thrilled to welcome Nanome to Science Exchange’s platform of more than 2,500 qualified providers that allow researchers access to innovative scientific technologies and services to advance their discoveries,” said Elizabeth Iorns, Ph.D., co-founder and CEO of Science Exchange. “Our global community of scientists can now instantly access Nanome’s virtual reality drug design and development tool to better visualize complex 3D data through immersive applications.”

About Nanome

Nanome primarily helps medicinal chemists and structural biologists understand complex molecular data through immersive and collaborative applications that facilitate faster pattern recognition, better molecular visualization, and a more efficient drug design and drug discovery process. The Matryx blockchain platform enables researchers to collaborate and share results while securing their intellectual property through the blockchain.

Take 5: January 2018

January 13, 2018 | Posted by Team in Drug Discovery, New Innovations, Research |

by Gursatya “Guru” Singh, Director of Scientific Content, Science Exchange

In 2017, we zealously scouted for innovative new technologies and external research partners that can help accelerate the speed of your R&D and take your science to market via the fastest path. Once identified, these resources are made accessible, hassle-free, through the Science Exchange Marketplace.

We remain steadfastly dedicated to this pursuit in 2018, so every month you will get a sneak peek of the five innovations from our recent marketplace additions that are worth your attention. Sit back and Take 5! If something grabs your interest, click on the provided link to learn more about each service.

 

TLA TECHNOLOGY FOR TARGETED NGS OF GENES THAT MATTER

This technology provides complete sequence information of genes, oncogenes in patients, and transgenes, integration sites and gene editing events in (CHO) cell lines and animal models.

By designing a primer pair specific for a locus of interest, TLA enables the amplification and sequencing of > 10,000s of basepairs of surrounding sequence information.

LEARN MORE

 

VariantFind multisite saturation mutagenesisVARIANTFIND™ (AKA MULTISITE SATURATION MUTAGENESIS)

This flexible and scalable PCR-based platform can create DNA libraries for any gene of interest.

The platform is not limited by target gene length or %GC composition and all variants are generated by using a targeted mutagenesis approach.

LEARN MORE

 

 

 

3D Drug ScreeningCOMPLEX 3D DRUG SCREENING

This technology involves patented microplates, in standard 384-well format, but with each well containing 150 individual microwells, in each of which can be grown a different 3D cell culture/spheroid.

This ultra-high-throughput platform improves data consistency and reduces the number of replicate plates required, saving time and money for the investigator.

LEARN MORE

 

Pathogen TestingXPLORE-NGS PATHOGEN TESTING SERVICE

This service can identify all the known pathogens including bacteria, viruses, and even fungi simultaneously in a single test using sequencing and genomic analysis approaches.

With genetic sequencing and advanced informatics, Xplore-NGS testing produces faster and more accurate results than culture-based methods and other molecular-based approaches.

LEARN MORE

 

 

Tissue Phantom DevelopmentTISSUE PHANTOM DEVELOPMENT

This technology uses hydrogel formulations to mimic properties of native tissue, such as fat, muscle, and skin. Resulting “phantoms” can be used to test medical devices and surgical tools.

Some of the diverse applications of tissue phantoms include skin substitutes for testing sutures, casts of major organs for surgical training, and arterial models of atherosclerosis and cardiovascular disease.

LEARN MORE

 

Request quotes for these innovative services today!

request quotes button

Science Exchange Partners with Lab Launch to Help its Startups Advance Scientific Innovations

January 10, 2018 | Posted by Team in Press Release |

Lab Launch Science Exchange Enterprise Outsourcing PlatformPalo Alto, CA – January 10, 2018 — Science Exchange, the world’s leading and most secure enterprise platform for outsourced research and development (R&D), teamed up today with Lab Launch, a nonprofit working to provide affordable and high-quality laboratories to biotech startups. This partnership with Science Exchange allows Lab Launch’s resident companies to easily supplement and complement their in-house resources with external research tools, technologies, and expertise.

Science Exchange enables immediate access to over 2,500+ commercial CROs, academic labs, and government facilities under a single marketplace agreement, in addition to a 24/7 PhD-level support by Science Exchange staff scientists.

“Our goal is to give LA-based scientists and entrepreneurs every opportunity to further their ideas and innovations in a way that is affordable and that will also give them access to the best scientific resources available,” said Marie Rippen, CEO of Lab Launch.  “By partnering with Science Exchange, Lab Launch can now offer our companies access to fully vetted service providers in a secure environment, so our scientists can devote time to advancing their ideas instead of being bogged down with administrative tasks including researching and negotiating with service providers.”

“Lab Launch and Science Exchange are both driven to give scientists the tools and support they need to be successful in developing their breakthrough ideas,” said Elizabeth Iorns, Ph.D., co-founder and CEO of Science Exchange. “Scientists at Lab Launch will now automatically gain access to the best scientific providers to help bring groundbreaking discoveries to market. We are excited to be part of the process!”

Lab Launch is the latest R&D organization to choose to partner with Science Exchange and joins more than 30 enterprise clients and Life Science incubators that are effectively managing their outsourced R&D with Science Exchange-powered marketplaces.

About Lab Launch

Lab Launch Inc is a 501(c)(3) non-profit working to establish a more dynamic biotech startup environment in Los Angeles. Our mission is to enable LA’s scientists and entrepreneurs to develop their ideas in affordable, high-quality lab facilities, with access to services and a supportive innovation community to accelerate their success.

 

Request a demo of Science Exchange’s platform to see how your organization can benefit from increased access to innovation and organizational efficiency.

About Science Exchange

We are transforming scientific collaboration by creating a marketplace where scientists can order experiments from the world's top labs.

Check the Science Exchange blog for updates, opinions, guest posts and the latest happenings at Science Exchange HQ!

Visit Science Exchange →

Subscribe to the blog
Never miss a post! Science Exchange blog posts delivered right to your inbox.
Thank you for joining the SciEx revolution!
Powered By WPFruits.com